According to researchers the identification of a key molecule that controls the growth, spread and survival of pancreatic cancer cells could be a promising step toward new and better treatment options for pancreatic cancer .
Researchers say they have discovered what role the GSK-3 Beta molecule plays in pancreatic cancer and that they have found the molecule is critical in pancreatic cancer cell growth and survival through its effect on NF Kappa B -- a well-known cancer cell gene regulator.
According to the study, the finding gives researchers a new way to target the key pancreatic cancer-promoting molecules with smaller molecules to inhibit their action. Researchers also believe the finding can lead to a method to make pancreatic cancer cells more receptive to gemcitabine, the only drug currently available for the disease.
Thus in conclusion researchers say their finding holds promise, for the development of new strategies to help fight other types of cancer.